Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

NCT01553123 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Leiomyomas

Interventions

DRUG: Ulipristal Acetate
DRUG: Iron

Sponsor

Watson Pharmaceuticals